Canada Finds Patents No Help For Poorest In Need Of Medicine 02/11/2009 by Intellectual Property Watch 3 Comments [Editor’s Note on 3 November: the report appears to be restricted access] Canada’s National Bureau of Economic Research today released a report on the relationship between patent protection for pharmaceuticals and investment in development of new drugs since the negotiation of the 1994 World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). […]
Changing Winds For Gene Patenting In the US? Stakeholders React To Draft Report 29/10/2009 by Catherine Saez, Intellectual Property Watch 1 Comment A United States health department advisory group this month produced a new draft report on gene patenting and licensing with recommendations suggesting that excessive patenting can limit patients’ access to gene testing and might not foster genetic research. The recommendations were supported by a variety of health professionals but put the biotechnology industry on edge.
US Federal Circuit May Offer Patent, Tech Policy Guidance For High Court 23/10/2009 by Winter Casey for Intellectual Property Watch 1 Comment WASHINGTON, DC – The United States Federal Circuit Court of Appeals should act more like a teacher to the Supreme Court and do a better job explaining its policy reasoning when it makes decisions on innovation-related cases, a top patent law academic said late Tuesday. If the Federal Circuit was clearer in how it landed at certain conclusions in patent disputes it might result in the Supreme Court opting to get involved in fewer patent cases, said Rochelle Dreyfuss, a professor at New York University School of Law.
Academics Debate Patent “Exhaustion Doctrine” 20/10/2009 by Intellectual Property Watch Leave a Comment Can a patent-holder ask for royalties from third-party purchasers? The United States Supreme Court said ‘no’ in the 2008 landmark case Quanta Computer Inc. v. LG Electronics Inc. (IPW, US Policy, 25 June 2008). But what does this decision mean for both patent law and rights holders? Five academics – Richard A. Epstein, F. Scott […]
Biotech Legislative Agenda: Healthcare, Energy, Patents And Capital 05/10/2009 by Liza Porteus Viana, Intellectual Property Watch Leave a Comment The United States Congress and biotechnology industry are currently focused on healthcare reform, but biotech is also looking to the future at energy reform, patent reform and other intellectual property-related legislative priorities still on its agenda.
Third Revision of Patent Law in China (Part II) 01/10/2009 by Intellectual Property Watch 4 Comments The third amendment of Chinese Patent Law enters into force from 1 October, 2009. This article by Wenting Cheng explores the major changes in substantive requirements for patent grant, post-grant enforcement and adaptation of Chinese Patent Law to international norms on the protection of intellectual property.
WIPO: Patents, Trademarks Tied To Economic Cycles But Crisis Impact Uneven 20/09/2009 by William New, Intellectual Property Watch 1 Comment World Intellectual Property Organization Director General Francis Gurry was accompanied publicly for the first time by the United Nations agency’s first economist as they presented data Friday showing the positive correlation between patent applications and economic cycles.
Brimelow Stresses Need For Better Patent System; Discusses Harmonisation 17/09/2009 by Kaitlin Mara for Intellectual Property Watch 1 Comment The way the patent system is currently structured rewards slowness and low quality, but the needed changes will have to include a new revenue model, a top European patent official said today.
Will KSR‘s Effect On Small Molecule Patents Be Limited? 14/09/2009 by Intellectual Property Watch Leave a Comment Four recent Federal Circuit decisions suggest that small molecules are special and may be relatively unaffected by the US Supreme Court KSR decision, write Photon Rao and George Best.
Third Revision Of Patent Law In China 08/09/2009 by Intellectual Property Watch 5 Comments The third amendment of China’s patent law will enter into force from 1 October, 2009. In this article, Wenting Cheng explores the major changes in substantive requirements for patent grant, post grant enforcement and adaptation of Chinese patent law to international norms on the protection of intellectual property.